Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.

Ramirez M, Rajaram S, Steininger RJ, Osipchuk D, Roth MA, Morinishi LS, Evans L, Ji W, Hsu CH, Thurley K, Wei S, Zhou A, Koduru PR, Posner BA, Wu LF, Altschuler SJ. · 2016

Read Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. by Ramirez M, Rajaram S, Steininger RJ, Osipchuk D, Roth MA, Morinishi LS, Evans L, Ji W, Hsu CH, Thurley K, Wei S, Zhou A, Koduru PR, Posner BA, Wu LF, Altschuler SJ. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4762880.txt.

Description

Michael Ramirez leads a large author team in Nature Communications in 2016 on how lung cancer cells escape a targeted drug. Some cells survive drug treatment by going quiet, growing almost not at all. These persister cells were suspected to be a waiting room from which true resistance later steps out, but how wide the escape routes ran was unknown.

Starting from one drug-sensitive lung cancer line, the team grew colonies that beat the drug erlotinib after passing through the quiet state. Screens and gene reads showed the colonies had not found one trick but many, among them the very routes seen in patients. The quiet state, the authors conclude, does not narrow the paths to resistance; it banks cells from which many paths can open.

Catalog record

CREATORRamirez M, Rajaram S, Steininger RJ, Osipchuk D, Roth MA, Morinishi LS, Evans L, Ji W, Hsu CH, Thurley K, Wei S, Zhou A, Koduru PR, Posner BA, Wu LF, Altschuler SJ.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4762880

Browse the full library · About the Tower of Babel